Please join IASN for a Virtual Town Hall on November 16th.

Applying Shared Decision-Making in Non-Hodgkin’s Lymphoma Treatment and Management to Optimize Multidisciplinary Care

1.0 CE Available Upon Completion

Sponsored by: Xeris Pharmaceuticals

Program Chair & Faculty Presenter
Mehdi Hamadani, MD
Professor of Medicine
Director, BMT, and Cellular Therapy Program
Medical College of Wisconsin, Milwaukee, WI

TARGET AUDIENCE
This program will reach the medical oncology team, including dermatologic oncologists, general oncologists, and multidisciplinary healthcare professionals working collaboratively to provide the best care for Non-Hodgkin’s Lymphoma (NHL) patients.

LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
– Examine the latest updates in novel-targeted and imuno-therapeutic treatment approaches.
– Identify potential unique adverse events associated with novel therapeutics and implement patient-centric education, monitoring, and reporting protocols.
– Integrate best practices for patient education and communication, including strategies for discussing treatment options, concerns and monitoring for/managing adverse events.
– Establish best practices for peer-to-peer expert communication for optimal multidisciplinary care of patients with Non-Hodgkin’s Lymphoma.

ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

DOWNLOAD OFFICIAL FLYER